Get started
Author

Nelleke P.B. Ottevanger

Observed names: N Ottevanger, N. B. Ottevanger, N. Ottevanger, N., Ottevanger, Nelleke (P.) B. Ottevanger, Nelleke Ottevanger, Nelleke P B Ottevanger, Nelleke P. Ottevanger, Ottevanger, Nelleke
Observed institutions: European Organisation for Research and Treatment of Cancer, Radboud University Nijmegen, Charles University, Radboud University Medical Center, European Organisation for Research and Treatment of Cancer, AGO Austria, Canadian Cancer Trials Group, UCLouvain, KU Leuven
ORCID: 0000-0001-8209-487X
Observed ORCID: 0000-0001-8209-487X
OpenAlex ID: A5059451765
Cancer During Pregnancy: An Analysis of 215 Patients Emphasizing the Obstetrical and the Neonatal Outcomes
2009 · Kristel Van Calsteren, Liesbeth Heyns, et al. · Journal of Clinical Oncology · 467
PDF
Breast cancer in pregnancy: Recommendations of an international consensus meeting
2010 · Frédéric Amant, Sarah Deckers, et al. · European Journal of Cancer · 304
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup
2022 · Ignace Vergote, Antonio Gonzalez-Martin, et al. · The Lancet Oncology · 139
Pharmacokinetics of chemotherapeutic agents in pregnancy: a preclinical and clinical study
2010 · Kristel Van Calsteren, René Verbesselt, et al. · Acta Obstetricia Et Gynecologica Scandinavica · 123
PDF
Practical clinical guidelines of the EOTTD for treatment and referral of gestational trophoblastic disease
2020 · Christianne Lok, Nienke van Trommel, et al. · European Journal of Cancer · 118
PDF
Randomized Phase III Study Comparing Neoadjuvant Chemotherapy Followed by Surgery Versus Chemoradiation in Stage IB2-IIB Cervical Cancer: EORTC-55994
2023 · Gemma G. Kenter, Stefano Greggi, et al. · Journal of Clinical Oncology · 108
Gynecologic Cancers in Pregnancy: Guidelines of an International Consensus Meeting
2009 · Frédéric Amant, Kristel Van Calsteren, et al. · International Journal of Gynecological Cancer · 106
Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study
2023 · Ignace Vergote, Els Van Nieuwenhuysen, et al. · Journal of Clinical Oncology · 89
PDF
Recurrent Endometrial Cancer: Local and Systemic Treatment Options
2021 · Heidi Rütten, Cornelia Verhoef, et al. · Cancers · 78
PDF
Harnessing natural killer cells for the treatment of ovarian cancer
2020 · Janneke S. Hoogstad-van Evert, Ruud Bekkers, et al. · Gynecologic Oncology · 78
Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition
2019 · Janet R Vos, Ingrid E Fakkert, et al. · JNCI Journal of the National Cancer Institute · 67
PDF
Fifth Ovarian Cancer Consensus Conference: individualized therapy and patient factors
2017 · J. McGee, M. Bookman, et al. · Annals of Oncology · 65
PDF
Practical Guidelines for the Treatment of Gestational Trophoblastic Disease: Collaboration of the European Organisation for the Treatment of Trophoblastic Disease (EOTTD)–European Society of Gynaecologic Oncology (ESGO)–Gynecologic Cancer InterGroup (GCIG)–International Society for the Study of Trophoblastic Diseases (ISSTD)
2025 · Christianne Lok, Nienke van Trommel, et al. · Journal of Clinical Oncology · 49
Long-Term Toxicity and Health-Related Quality of Life After Adjuvant Chemoradiation Therapy or Radiation Therapy Alone for High-Risk Endometrial Cancer in the Randomized PORTEC-3 Trial
2020 · Cathalijne C.B. Post, Stephanie M. de Boer, et al. · International Journal of Radiation Oncology*Biology*Physics · 47
PDF
Oncologic multidisciplinary team meetings: evaluation of quality criteria
2013 · Nelleke Ottevanger, Mirrian Hilbink, et al. · Journal of Evaluation in Clinical Practice · 44
Intraperitoneal infusion of ex vivo-cultured allogeneic NK cells in recurrent ovarian carcinoma patients (a phase I study)
2019 · Janneke Hoogstad-van Evert, Ruud Bekkers, et al. · Medicine · 30
Role of Molecular Agents and Targeted Therapy in Clinical Trials for Women With Ovarian Cancer
2011 · Jonathan A. Ledermann, Christian Marth, et al. · International Journal of Gynecological Cancer · 29
Myocardial function in children after fetal chemotherapy exposure. A tissue Doppler and myocardial deformation imaging study
2012 · Mina Mhallem Gziri, Wei Hui, et al. · European Journal of Pediatrics · 28
Gynecologic oncology in pregnancy
2008 · Frédéric Amant, Kristel Van Calsteren, et al. · Critical Reviews in Oncology/Hematology · 28
INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line
2023 · N. Colombo, A. Gadducci, et al. · British Journal of Cancer · 27
PDF
Increased peritoneal TGF-β1 is associated with ascites-induced NK-cell dysfunction and reduced survival in high-grade epithelial ovarian cancer
2024 · Ralph J. A. Maas, Janneke S. Hoogstad-van Evert, et al. · Frontiers in Immunology · 23
PDF
LBA30 INOVATYON study: Randomized phase III international study comparing trabectedin/PLD followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line
2020 · N. Colombo, A. Gadducci, et al. · Annals of Oncology · 23
Cardiovascular surveillance in breast cancer treatment: A more individualized approach is needed
2016 · Angela H.E.M. Maas, Nelleke Ottevanger, et al. · Maturitas · 12
Cemiplimab plus peltopepimut-S vaccine in recurrent cervical cancer: A phase 2 clinical trial
2025 · Domenica Lorusso, Ana Oaknin, et al. · Gynecologic Oncology · 10
PDF
596 A randomised phase II study of nintedanib (BIBF1120) compared to chemotherapy in patients with recurrent clear cell carcinoma of the ovary or endometrium. (NICCC/ENGOT-OV36)
2020 · Rosalind Glasspool, Iain Mcneish, et al. · International Journal of Gynecological Cancer · 10
PDF
Works count: 67
Citation count: 2,142
H-index: 22
I10-index: 26
Year
Topic
Type